Renal allograft rejection: The contribution of chemokines to the adhesion and retention of αE(CD103)β7 integrin-expressing intratubular T cells

Molecular Immunology

Volumn 45, Issue 15, 2008, Pages 4000-4007

  Al Hamidi, Abdulaziz ^a   Pekalski, Marcin ^a   Robertson, Helen ^a   Ali, Simi ^a   Kirby, John A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

E 7 integrin; Adhesion; Allograft rejection; Chemokine; E cadherin; Kidney

Indexed keywords

ALPHAEBETA7 INTEGRIN; CD103 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTEGRIN; MANGANESE; MONOCYTE CHEMOTACTIC PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY GRAFT REJECTION; KIDNEY TUBULE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CHEMOKINES; GRAFT REJECTION; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRIN BETA CHAINS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 49449092232     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.06.011     Document Type: Article

References (39)

1. Al-Hamidi A., Tyler J.R., Robertson H., and Kirby J.A. Kidney transplantation: does CCR9 play a role in rejection?. Immunology 116 Suppl. 1 (2005) 107
2. Ali S., Malik G., Burns A., Robertson H., and Kirby J.A. Renal transplantation: examination of the regulation of chemokine binding during acute rejection. Transplantation 79 (2005) 672-679
3. Allakhverdi Z., Fitzpatrick D., Boisvert A., Baba N., Bouguermouh S., Sarfati M., and Delespesse G. Expression of CD103 identifies human regulatory T-cell subsets. J. Allergy Clin. Immunol. 118 (2006) 1342-1349
4. Anders H.J., Ninichuk V., and Schlondorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int. 69 (2006) 29-32
5. Cerf-Bensussan N., Jarry A., Brousse N., Lisowska-Grospierre B., Guy-Grand D., and Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur. J. Immunol. 17 (1987) 1279-1285
6. Corps E.M., Robertson A., Dauncey M.J., and Kilshaw P.J. Role of the alphaI domain in ligand binding by integrin alphaEbeta7. Eur. J. Immunol. 33 (2003) 2599-2608
7. Ericsson A., Svensson M., Arya A., and Agace W.W. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes. Eur. J. Immunol. 34 (2004) 2720-2729
8. Feigelson S.W., Grabovsky V., Winter E., Chen L.L., Pepinsky R.B., Yednock T., Yablonski D., Lobb R., and Alon R. The Src kinase p56(lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin. J. Biol. Chem. 276 (2001) 13891-13901
9. Feng Y., Wang D., Yuan R., Parker C.M., Farber D.L., and Hadley G.A. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J. Exp. Med. 196 (2002) 877-886
10. French J.J., Cresswell J., Wong W.K., Seymour K., Charnley R.M., and Kirby J.A. T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?. Br. J. Cancer 87 (2002) 1034-1041
11. Gourishankar S., and Halloran P.F. Late deterioration of organ transplants: a problem in injury and homeostasis. Curr. Opin. Immunol. 14 (2002) 576-583
12. Grone H.J., Weber C., Weber K.S., Grone E.F., Rabelink T., Klier C.M., Wells T.N., Proudfood A.E., Schlondorff D., and Nelson P.J. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. Faseb J. 13 (1999) 1371-1383
13. Hancock W.W., Gao W., Faia K.L., and Csizmadia V. Chemokines and their receptors in allograft rejection. Curr. Opin. Immunol. 12 (2000) 511-516
14. Higgins J.M., Mandlebrot D.A., Shaw S.K., Russell G.J., Murphy E.A., Chen Y.T., Nelson W.J., Parker C.M., and Brenner M.B. Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J. Cell Biol. 140 (1998) 197-210
15. Horuk R., Shurey S., Ng H.P., May K., Bauman J.G., Islam I., Ghannam A., Buckman B., Wei G.P., Xu W., Liang M., Rosser M., Dunning L., Hesselgesser J., Snider R.M., Morrissey M.M., Perez H.D., and Green C. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol. Lett. 76 (2001) 193-201
16. Inston N.G., and Cockwell P. The evolving role of chemokines and their receptors in acute allograft rejection. Nephrol. Dial. Transplant. 17 (2002) 1374-1379
17. Kilshaw P.J. AlphaEbeta7. Mol. Pathol. 52 (1999) 203-207
18. Lin Y., Kirby J.A., Browell D.A., Morley A.R., Shenton B.K., Proud G., and Taylor R.M.R. Renal-allograft rejection-expression and function of VCAM-1 on tubular epithelial-cells. Clin. Exp. Immunol. 92 (1993) 145-151
19. Mayer V., Hudkins K.L., Heller F., Schmid H., Kretzler M., Brandt U., Anders H.J., Regele H., Nelson P.J., Alpers C.E., Schlondorff D., and Segerer S. Expression of the chemokine receptor CCR1 in human renal allografts. Nephrol. Dial. Transplant. 22 (2007) 1720-1729
20. McFarland R.D., Douek D.C., Koup R.A., and Picker L.J. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4215-4220
21. Menten P., Wuyts A., and Van Damme J. Monocyte chemotactic protein-3. Eur. Cytokine Netw. 12 (2001) 554-560
22. Mueller A., Mahmoud N.G., Goedecke M.C., McKeating J.A., and Strange P.G. Pharmacological characterization of the chemokine receptor, CCR5. Br. J. Pharmacol. 135 (2002) 1033-1043
23. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., Croker B.P., Demetris A.J., Drachenberg C.B., Fogo A.B., Furness P., Gaber L.W., Gibson I.W., Glotz D., Goldberg J.C., Grande J., Halloran P.F., Hansen H.E., Hartley B., Hayry P.J., Hill C.M., Hoffman E.O., Hunsicker L.G., Lindblad A.S., Yamaguchi Y., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55 (1999) 713-723
24. Robertson H., Ali S., McDonnell B.J., Burt A.D., and Kirby J.A. Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J. Am. Soc. Nephrol. 15 (2004) 390-397
25. Robertson H., and Kirby J.A. Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells. Am. J. Transplant. 3 (2003) 3-10
26. Robertson H., Morley A.R., Talbot D., Callanan K., and Kirby J.A. Renal allograft rejection: beta-chemokine involvement in the development of tubulitis. Transplantation 69 (2000) 684-687
27. Robertson H., Wheeler J., Thompson V., Johnson J.S., Kirby J.A., and Morley A.R. In situ lymphoproliferation in renal transplant biopsies. Histochem. Cell Biol. 104 (1995) 331-334
28. Rostapshova E.A., Burns J.M., Bartlett S.T., and Hadley G.A. Integrin-mediated interactions influence the tissue specificity of CD8+ cytolytic T lymphocytes. Eur. J. Immunol. 28 (1998) 3031-3039
29. Ruster M., Sperschneider H., Funfstuck R., Stein G., and Grone H.J. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin. Nephrol. 61 (2004) 30-39
30. Sarnacki S., Begue B., Buc H., Le Deist F., and Cerf-Bensussan N. Enhancement of CD3-induced activation of human intestinal intraepithelial lymphocytes by stimulation of the beta 7-containing integrin defined by HML-1 monoclonal antibody. Eur. J. Immunol. 22 (1992) 2887-2892
31. Shimaoka M., Kim M., Cohen E.H., Yang W., Astrof N., Peer D., Salas A., Ferrand A., and Springer T.A. AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 13991-13996
32. Shinozaki M., Hirahashi J., Lebedeva T., Liew F.Y., Salant D.J., Maron R., and Kelley V.R. IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J. Clin. Invest. 109 (2002) 951-960
33. Shiraishi K., Tsuzaka K., Yoshimoto K., Kumazawa C., Nozaki K., Abe T., Tsubota K., and Takeuchi T. Critical role of the fifth domain of E-cadherin for heterophilic adhesion with alphaEbeta7, but not for homophilic adhesion. J. Immunol. 175 (2005) 1014-1021
34. Solez K., Racusen L.C., Abdulkareem F., Kemeny E., von Willebrand E., and Truong L.D. Adhesion molecules and rejection of renal allografts. Kidney Int. 51 (1997) 1476-1480
35. Uss E., Rowshani A.T., Hooibrink B., Lardy N.M., van Lier R.A., and ten Berge I.J. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J. Immunol. 177 (2006) 2775-2783
36. Vongwiwatana A., Tasanarong A., Rayner D.C., Melk A., and Halloran P.F. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am. J. Transplant. 5 (2005) 1367-1374
37. Wilson J.L., Cunningham A.C., and Kirby J.A. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation. Immunology 86 (1995) 325-330
38. Wong W.K., Robertson H., Carroll H.P., Ali S., and Kirby J.A. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells. Transplantation 75 (2003) 505-514
39. Yuan R., El-Asady R., Liu K., Wang D., Drachenberg C.B., and Hadley G.A. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation. J. Immunol. 175 (2005) 2868-2879